Oak Family Advisors LLC Sells 3,328 Shares of Agilent Technologies, Inc. (NYSE:A)

Oak Family Advisors LLC reduced its position in Agilent Technologies, Inc. (NYSE:A) by 67.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,621 shares of the medical research company’s stock after selling 3,328 shares during the period. Oak Family Advisors LLC’s holdings in Agilent Technologies were worth $218,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. CKW Financial Group increased its position in shares of Agilent Technologies by 114.9% during the fourth quarter. CKW Financial Group now owns 187 shares of the medical research company’s stock valued at $25,000 after acquiring an additional 100 shares during the last quarter. Livelsberger Financial Advisory purchased a new position in shares of Agilent Technologies in the 3rd quarter worth about $28,000. Ashton Thomas Securities LLC purchased a new position in shares of Agilent Technologies in the 3rd quarter worth about $31,000. Fortitude Family Office LLC grew its position in Agilent Technologies by 68.3% during the third quarter. Fortitude Family Office LLC now owns 234 shares of the medical research company’s stock valued at $35,000 after buying an additional 95 shares during the period. Finally, Hanson & Doremus Investment Management increased its holdings in Agilent Technologies by 66.5% during the fourth quarter. Hanson & Doremus Investment Management now owns 263 shares of the medical research company’s stock worth $35,000 after buying an additional 105 shares during the last quarter.

Insider Transactions at Agilent Technologies

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,911 shares of Agilent Technologies stock in a transaction that occurred on Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total transaction of $286,650.00. Following the transaction, the chief executive officer now owns 39,652 shares of the company’s stock, valued at $5,947,800. The trade was a 4.60 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Agilent Technologies Trading Up 0.2 %

Shares of NYSE:A opened at $151.75 on Monday. The company has a debt-to-equity ratio of 0.57, a current ratio of 2.09 and a quick ratio of 1.58. Agilent Technologies, Inc. has a 1 year low of $124.16 and a 1 year high of $155.35. The company has a market cap of $43.34 billion, a P/E ratio of 34.33, a PEG ratio of 3.98 and a beta of 1.06. The stock’s fifty day moving average price is $140.52 and its 200-day moving average price is $138.81.

Agilent Technologies (NYSE:A) last issued its earnings results on Monday, November 25th. The medical research company reported $1.46 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.41 by $0.05. The company had revenue of $1.70 billion for the quarter, compared to analysts’ expectations of $1.67 billion. Agilent Technologies had a net margin of 19.80% and a return on equity of 25.43%. The firm’s quarterly revenue was up .8% on a year-over-year basis. During the same quarter last year, the company posted $1.38 earnings per share. Sell-side analysts expect that Agilent Technologies, Inc. will post 5.56 earnings per share for the current year.

Agilent Technologies Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, January 22nd. Stockholders of record on Tuesday, December 31st were paid a dividend of $0.248 per share. This represents a $0.99 annualized dividend and a dividend yield of 0.65%. The ex-dividend date of this dividend was Tuesday, December 31st. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.24. Agilent Technologies’s dividend payout ratio (DPR) is currently 22.40%.

Analyst Upgrades and Downgrades

Several brokerages have commented on A. JPMorgan Chase & Co. cut their price target on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a report on Tuesday, November 26th. StockNews.com upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Tuesday, December 24th. Bank of America lowered their price target on Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating on the stock in a report on Friday, December 13th. Barclays cut their price objective on Agilent Technologies from $145.00 to $135.00 and set an “underweight” rating for the company in a report on Wednesday, November 27th. Finally, Sanford C. Bernstein dropped their target price on shares of Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating for the company in a research report on Tuesday, November 26th. One analyst has rated the stock with a sell rating, six have given a hold rating and eight have assigned a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $143.62.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.